Context Once believed to represent a uniform malignant phenotype, renal cell carcinoma
(RCC) is now viewed as a diverse group of cancers that arise from the nephron. Objective …

The field of immunotherapy is a continually expanding niche in cancer biology research. In
the last two decades, there has been significant progress in identifying better targets and …

We describe the landscape of somatic genomic alterations of 66 chromophobe renal cell
carcinomas (ChRCCs) on the basis of multidimensional and comprehensive …

Abstract The International Society of Urological Pathology 2012 Consensus Conference
made recommendations regarding classification, prognostic factors, staging, and …

Purpose Mature survival data and evaluation of vascular endothelial growth factor (VEGF)
as a prognostic biomarker from the Treatment Approaches in Renal Cancer Global …

Purpose: Currently outcome prediction in renal cell carcinoma is largely based on
pathological stage and tumor grade. We developed an outcome prediction model for …

Our objective was to compare cancer-specific survival and to examine associations with
outcome among the histologic subtypes of renal cell carcinoma (RCC). We studied 2385 …

Purpose: We examined the relationship between tumor size and malignancy among solid
renal tumors, and the relationship between tumor size and RCC subtype within tumors with …

The treatment landscape of metastatic renal cell carcinoma (RCC) has been revolutionized
over the past two decades, bringing forth an era in which more than a dozen therapeutic …

Purpose Pathological parameters assessed on biopsies and resection specimens have a
pivotal role in the diagnosis, prognosis and management of patients with renal cell …